MACK: Merrimack Pharmaceuticals, Inc. Stock

by  •  • Comments Off on MACK: Merrimack Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 214.20
Enterprise Value ($M) 208.21
Book Value ($M) 18.75
Book Value / Share 1.29
Price / Book 11.43
NCAV ($M) 18.74
NCAV / Share 1.29
Price / NCAV 11.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.06
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.06

Liquidity (mrq)
Quick Ratio 43.50
Current Ratio 43.50

Balance Sheet (mrq) ($M)
Current Assets 19.18
Assets 19.19
Liabilities 0.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -2.18
Net Income -1.18
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.52
Cash from Investing -12.45
Cash from Financing 0.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-07 13G/A BlackRock Inc. 4.99 -3.81
02-14 13G/A 22NW Fund, LP 0.00 -100.00
01-25 13D/A Newtyn Management, LLC 13.10 23.34
12-13 13D/A Western Standard LLC 15.50 11.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the fiscal year ended December 31, 2023 ☐ Transition rep
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 35,658 299,551 11.90
2024-04-30 6,976 44,086 15.82
2024-04-29 12,177 28,356 42.94

(click for more detail)

Similar Companies
LRMR – Larimar Therapeutics, Inc. LUMO – Lumos Pharma, Inc.
LXEO – Lexeo Therapeutics, Inc. MDWD – MediWound Ltd.
MIRM – Mirum Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Merrimack Pharmaceuticals